V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20162775 | 20062829 | 1.6 | 129.8 | Neo-adjuvant (N) | 2019-10-26 | 2019-10-26 | ECX | null | N | ECX | 100061806 |
| 20162779 | 20062830 | 1.69 | 67.9 | Adjuvant (A) | 2017-11-17 | 2017-11-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101288782 |
| 20162784 | 20062831 | 1.71 | 59.7 | Palliative (P) | 2018-07-17 | 2018-07-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100036984 |
| 20162789 | 20062832 | 1.73 | 77.4 | Adjuvant (A) | 2019-08-20 | 2019-09-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101409855 |
| 20162791 | 20062833 | 1.68 | 75.7 | Curative (C) | 2018-07-28 | 2018-07-28 | ECX | N | N | ECX | 101592796 |
| 20162793 | 20062834 | null | 55.8 | Palliative (P) | 2017-09-30 | 2017-10-21 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100273894 |
| 20162796 | 20062835 | 1.6 | 87 | Neo-adjuvant (N) | 2017-03-15 | 2017-04-08 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101811980 |
| 20162811 | 20062836 | 1.74 | 69 | Adjuvant (A) | 2016-06-01 | 2016-06-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100063057 |
| 20162815 | 20062837 | 1.7 | 63 | Adjuvant (A) | 2019-02-10 | 2019-03-09 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101722543 |
| 20162819 | 20062838 | 1.8 | 80.1 | Adjuvant (A) | 2018-04-01 | 2018-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101187054 |
| 20162820 | 20062839 | 1.75 | 83.55 | Neo-adjuvant (N) | 2019-01-28 | 2019-02-09 | ECX | N | N | ECX | 101492823 |
| 20162822 | 20062840 | 1.63 | 68 | Palliative (P) | 2019-10-07 | 2019-10-21 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101326130 |
| 20162825 | 20062841 | 1.62 | 66 | Palliative (P) | 2017-10-21 | 2017-11-14 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100184340 |
| 20162828 | 20062842 | 1.69 | 68.1 | Palliative (P) | 2017-10-17 | 2017-10-24 | ECX | 2 | N | ECX | 101796007 |
| 20162833 | 20062843 | 1.57 | 71 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-08 | ECX | 02 | N | ECX | 101084735 |
| 20162837 | 20062844 | 1.58 | 55.5 | Adjuvant (A) | 2016-12-29 | 2017-03-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100462402 |
| 20162840 | 20062845 | 1.76 | 63.8 | Neo-adjuvant (N) | 2016-08-31 | 2016-09-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101609523 |
| 20162841 | 20062846 | 1.65 | 104.1 | Palliative (P) | 2020-01-02 | 2020-01-09 | ECX | N | N | ECX | 100591468 |
| 20162844 | 20062847 | 1.73 | 65.6 | Palliative (P) | 2016-07-02 | 2016-07-07 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100287712 |
| 20162847 | 20062848 | 1.6 | 79.8 | Neo-adjuvant (N) | 2019-11-11 | 2019-11-11 | ECX | 02 | N | ECX | 100978504 |
| 20162848 | 20062849 | 1.59 | 126 | Adjuvant (A) | 2019-07-31 | 2019-08-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101169351 |
| 20162863 | 20062850 | 1.55 | 73 | Adjuvant (A) | 2017-10-30 | 2017-11-17 | ECX | 2 | N | ECX | 101640765 |
| 20162866 | 20062851 | 1.58 | 82 | Neo-adjuvant (N) | 2018-10-30 | 2018-11-03 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101405127 |
| 20162872 | 20062852 | 1.65 | 104 | Palliative (P) | 2019-09-21 | 2019-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101185439 |
| 20162877 | 20062853 | 1.52 | 48.1 | Palliative (P) | 2019-02-24 | 2019-03-09 | ECX | N | N | ECX | 101663517 |
| 20162879 | 20062854 | 1.8 | 120 | Palliative (P) | 2019-03-09 | 2019-03-23 | ECX | N | N | ECX | 101420822 |
| 20162880 | 20062855 | 1.76 | 70.3 | Palliative (P) | 2019-12-03 | 2019-12-03 | ECX | N | N | ECX | 100916413 |
| 20162881 | 20062856 | 1.5 | 54 | Neo-adjuvant (N) | 2016-12-15 | 2017-01-01 | ECX | 02 | N | ECX | 100024229 |
| 20162889 | 20062857 | 1.84 | 60.8 | Curative (C) | 2017-02-26 | 2017-03-08 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100112262 |
| 20162893 | 20062858 | 1.72 | 82.4 | Curative (C) | 2016-07-29 | 2016-07-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101051874 |
| 20162898 | 20062859 | 1.67 | 72.2 | Neo-adjuvant (N) | 2018-02-21 | 2018-02-24 | ECX | N | N | ECX | 101056979 |
| 20162899 | 20062860 | 1.63 | 80 | Adjuvant (A) | 2019-08-06 | 2019-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100639962 |
| 20162904 | 20062861 | 1.74 | 65.9 | Curative (C) | 2019-09-14 | 2019-09-22 | ECX | N | N | ECX | 101743238 |
| 20162905 | 20062862 | 1.73 | 73.6 | Neo-adjuvant (N) | null | 2017-02-24 | ECX | N | N | ECX | 101781644 |
| 20162907 | 20062863 | 1.52 | 54.8 | Neo-adjuvant (N) | 2017-07-13 | 2017-08-16 | ECX | N | N | ECX | 101789700 |
| 20162908 | 20062864 | 1.7 | 85.4 | null | 2016-08-28 | 2016-09-02 | ECX | 2 | N | ECX | 100761176 |
| 20162919 | 20062865 | 1.63 | null | Palliative (P) | 2018-08-04 | 2018-08-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101157189 |
| 20162922 | 20062866 | 1.68 | 63 | Palliative (P) | 2018-11-06 | 2018-11-07 | ECX | N | N | ECX | 101696408 |
| 20162925 | 20062867 | 1.75 | 85.7 | Neo-adjuvant (N) | 2019-03-07 | 2019-03-21 | ECX | N | N | ECX | 101356315 |
| 20162933 | 20062868 | 1.55 | 54.8 | Palliative (P) | 2018-03-25 | 2018-03-25 | ECX | 02 | N | ECX | 101604318 |
| 20162934 | 20062869 | 1.7 | 70.5 | Neo-adjuvant (N) | 2019-11-14 | 2019-11-19 | ECX | N | N | ECX | 100609634 |
| 20162935 | 20062870 | 1.47 | 82.55 | Adjuvant (A) | 2018-12-26 | 2019-01-10 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100572647 |
| 20162936 | 20062871 | 1.68 | 63.6 | 02 | 2019-12-11 | 2019-12-11 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101370098 |
| 20162940 | 20062872 | 1.5 | 74 | Palliative (P) | 2017-03-16 | 2017-03-29 | ECX | 2 | N | ECX | 101090531 |
| 20162942 | 20062873 | 1.73 | 83 | Palliative (P) | 2017-09-27 | 2017-11-05 | ECX | N | null | ECX | 101787967 |
| 20162945 | 20062874 | 1.52 | 57.6 | Neo-adjuvant (N) | 2016-01-24 | 2016-02-06 | ECX | N | N | ECX | 101806288 |
| 20162946 | 20062875 | 1.52 | 95 | Neo-adjuvant (N) | 2018-10-04 | 2018-10-14 | ECX | N | N | ECX | 100591836 |
| 20162959 | 20062876 | 1.82 | 77.9 | Neo-adjuvant (N) | 2016-09-16 | 2016-09-16 | ECX | 02 | N | ECX | 100048182 |
| 20162962 | 20062877 | 1.6 | 56.9 | Neo-adjuvant (N) | 2018-10-25 | 2018-11-02 | ECX | N | N | ECX | 101584493 |
| 20162963 | 20062878 | 1.85 | 66.2 | Neo-adjuvant (N) | 2018-05-29 | 2018-05-31 | ECX | 02 | N | ECX | 101729032 |